Department of Thoracic Surgery, Vanderbilt University Medical Center, Nashville, Tenn.
Department of Surgery, Columbia University Medical Center, New York, NY.
J Thorac Cardiovasc Surg. 2019 Apr;157(4):1696-1706. doi: 10.1016/j.jtcvs.2018.09.139. Epub 2018 Nov 29.
Extracorporeal membrane oxygenation (ECMO) is used to provide support for patients with cardiopulmonary failure. Best available medical management often fails in these patients and referring hospitals have no further recourse for escalating care apart from transfer to a tertiary facility. In severely unstable patients, the only option might be to use ECMO to facilitate safe transport. This study aimed to examine the characteristics and outcomes of patients transported while receiving ECMO.
Statistical analysis was performed on data gathered retrospectively from the electronic medical records of adult patients transported while receiving ECMO to Columbia University Medical Center between January 1, 2008, and December 31, 2017.
Two hundred sixty five adult patients were safely transported while receiving ECMO with no transport-related complications that adversely affected outcomes. Transport distance ranged from 0.2 to 7084 miles with a median distance of 16.9 miles. One hundred eighty-three (69%) received on veno-venous, 72 (27%) veno-arterial, and 10 (3.8%) veno-venous arterial or veno-arterial venous configurations. Two hundred ten (79%) cannulations were performed at our institution at the referring hospital. Sixty-four percent of patients transported while receiving ECMO survived to hospital discharge.
Interfacility transport during ECMO was shown to be safe and effective with minimal complications and favorable outcomes when performed at an experienced referral center using stringently applied protocols.
体外膜肺氧合(ECMO)用于为心肺衰竭患者提供支持。这些患者的最佳现有医疗管理往往失败,除了转至三级医疗机构外,转介医院没有进一步的治疗手段来升级治疗。在严重不稳定的患者中,唯一的选择可能是使用 ECMO 来促进安全转运。本研究旨在检查在接受 ECMO 治疗时转运的患者的特征和结局。
对 2008 年 1 月 1 日至 2017 年 12 月 31 日期间,在哥伦比亚大学医学中心接受 ECMO 转运的成年患者的电子病历中回顾性收集的数据进行统计分析。
265 名成年患者在接受 ECMO 转运时安全无并发症,没有对结局产生不利影响。转运距离为 0.2 至 7084 英里,中位数为 16.9 英里。183 例(69%)接受静脉-静脉、72 例(27%)静脉-动脉、10 例(3.8%)静脉-静脉-动脉或静脉-动脉-静脉配置。210 例(79%)在转介医院进行了插管。在接受 ECMO 转运的患者中,有 64%存活至出院。
在经验丰富的转介中心使用严格应用的方案进行转运时,体外膜肺氧合的院内转运是安全有效的,并发症少,结局良好。